c-RET
Read More about this categoryShow Less
The c-RET proto-oncogene, which was originally identified as a transforming gene by transfection of T-cell lymphoma DNA into NIH3T3 cells, is a member of the receptor tyrosine kinase (RTK) gene superfamily that encodes a receptor tyrosine kinase involved in the regulation of glial cell line-derived neurotrophic factor (GDNF) signaling. Signaling proteins, such as Grb7/Grb10, PLCγ, Shc/Enigma and Grb2, are recruited by activated c-RET protein through binding to the phosphorylated tyrosine residues in c-RET protein’s COOH-terminal sequence, Y905, Y1015, Y1062 and Y1096 respectively. Moreover, results of in vivo studies suggest mutations of c-RET have been implicated in tumorigenesis, in which c-RET mRNA and/or protein have been found in tumors of neuroectodermal origin as well as in human neuroblastoma cell lines.
Products Related to c-RET(8)
- GC13194RPI-1CAS: 269730-03-2Purity: >98.50%
RPI-1 est un inhibiteur spécifique de la 2-indolinone Ret tyrosine kinase disponible par voie orale. RPI-1 inhibe la prolifération, la phosphorylation de la tyrosine Ret, l'expression de la protéine Ret et l'activation de PLCgamma, ERK et AKT dans les cellules TT du carcinome médullaire de la thyroÏde humaine. Activité antitumorale.
- GC16362AD57 (hydrochloride)CAS: 2320261-72-9Purity: >98%
polypharmacological cancer therapeutic that inhibits RET.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC10035 | TG101209 | 936091-14-4 | >99.50% | |
An inhibitor of JAK2, FLT3, RET, and JAK3 | ||||
| GC13194 | RPI-1 | 269730-03-2 | >98.50% | |
RPI-1 est un inhibiteur spécifique de la 2-indolinone Ret tyrosine kinase disponible par voie orale. RPI-1 inhibe la prolifération, la phosphorylation de la tyrosine Ret, l'expression de la protéine Ret et l'activation de PLCgamma, ERK et AKT dans les cellules TT du carcinome médullaire de la thyroÏde humaine. Activité antitumorale. | ||||
| GC14534 | Regorafenib monohydrate | 1019206-88-2 | >99.50% | |
A multi-kinase inhibitor | ||||
| GC14606 | Regorafenib hydrochloride | 835621-07-3 | >99.50% | |
A multi-kinase inhibitor | ||||
| GC15217 | Danusertib (PHA-739358) | 827318-97-8 | >98.50% | |
A pan-Aurora kinase and Abl inhibitor | ||||
| GC15307 | SU5416 | 204005-46-9 | >98.00% | |
SU5416 est une petite molécule inhibitrice de Flk-1/KDR. Il empêche l'autophosphorylation du récepteur FIk-1, sa valeur d'IC50 est 1,23μM. | ||||
| GC16362 | AD57 (hydrochloride) | 2320261-72-9 | >98% | |
polypharmacological cancer therapeutic that inhibits RET. | ||||
| GC16391 | Amuvatinib (MP-470, HPK 56) | 850879-09-3 | >98.00% | |
A multi-targeted RTK inhibitor | ||||
